These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2693275)

  • 1. [Renewal of oral therapy for diabetes mellitus after secondary failure].
    Guberman D
    Harefuah; 1989 Nov; 117(9):240-1. PubMed ID: 2693275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combination therapy with insulin and oral hypoglycemic agents in patients with type II diabetes during a 1-year period.
    Mozersky RP; Patel H; Bahl VK; Bahl S; Mook W
    J Am Osteopath Assoc; 1996 Jun; 96(6):346-51. PubMed ID: 8690621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transitioning pharmacologic therapy from oral agents to insulin for type 2 diabetes.
    Tanenberg RJ
    Curr Med Res Opin; 2004 Apr; 20(4):541-53. PubMed ID: 15119992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed action of oral antidiabetic treatments. Place of combination of insulin and hypoglycemic sulfamides].
    Leutenegger M; Nakib Y; Grulet H; Gross A; Boirie Y
    Journ Annu Diabetol Hotel Dieu; 1993; ():97-114. PubMed ID: 8331877
    [No Abstract]   [Full Text] [Related]  

  • 9. [Inefficacy of oral antidiabetics: failure or natural history of diabetes?].
    Schönenweid C
    Rev Med Suisse Romande; 1995 Sep; 115(9):671-3. PubMed ID: 7481353
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin therapy for maximal glycemic control in type 2 diabetes mellitus.
    Spellman CW
    J Am Osteopath Assoc; 2007 Jul; 107(7):260-9. PubMed ID: 17682113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
    Leutenegger M; Bertin E; Grulet H
    Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in metabolic control after interruption of oral hypoglycemic agents in type II diabetic patients with secondary failure during combined therapy].
    De Mattia G; Laurenti O; Tullo MG; Ventura C; Albi F
    Clin Ter; 1988 Oct; 127(2):119-22. PubMed ID: 2976347
    [No Abstract]   [Full Text] [Related]  

  • 13. Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2.
    Pagkalos EM
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S100-1. PubMed ID: 21864738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insulin treatment in type 2 diabetes: epidemiological data].
    Papoz L
    Diabetes Metab; 2001 Nov; 27(5 Pt 3):S7-14. PubMed ID: 11910979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II diabetes: insulin versus oral agents.
    Martin DB
    N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646
    [No Abstract]   [Full Text] [Related]  

  • 20. The stepwise approach to the management of type 2 diabetes.
    Warren RE
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S3-8. PubMed ID: 15315864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.